Bendamustine for indolent lymphoma reduces relapse after 10 years

ShortHER trastuzumab treatment of HER2 breast cancer: 9 weeks v 1 year

T-VEC and checkpoint therapy for melanoma

Prevalence of homologous recombination deficiency among 53,000 tumour samples

Natural plant based balm antidote to severe nail toxicity during chemotherapy

Dacomitinib for EGFR positive lung cancer

New ALK inhibitor alectinib halts lung cancer growth more than a year longer than crizotinib, with fewer severe side effects

Treating advanced melanoma with ipilimumab and HF10

Ado-trastuzumab emtansine in patients with HER2 mutant lung cancers

Immunotherapy may slow the growth of malignant pleural mesothelioma

Immunotherapy for mesothelioma could be on the horizon

CAR T-cell therapy can be used to send multiple myeloma into lasting remission